CCL2-driven inflammation increases mammary gland stromal density and cancer susceptibility in a transgenic mouse model
Authors:
- Xuan SunXSXuan Sun
- Danielle J. GlynnDGDanielle J. Glynn
- Leigh J. HodsonLHLeigh J. Hodson
- Kara BrittKBKara Britt
- Erik W. ThompsonETErik W. Thompson
- Lucy WoolfordLWLucy Woolford
- Andreas EvdokiouAEAndreas Evdokiou
- Jeffrey W. PollardJeffrey W. Pollard
- Sarah A. RobertsonSRSarah A. Robertson
- Wendy V. IngmanWendy V. Ingman
Open Access
- 11 January 2017
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research
- Vol. 19 (1) , 1-15
Abstract
Macrophages play diverse roles in mammary gland development and breast cancer. CC-chemokine ligand 2 (CCL2) is an inflammatory cytokine that recruits macrophages to sites of injury. Although CCL2 has been detected in human and mouse mammary epithelium, its role in regulating mammary gland development and cancer risk has not been explored. Transgenic mice were generated wherein CCL2 is driven by the mammary epithelial cell-specific mouse mammary tumour virus 206 (MMTV) promoter. Estrous cycles were tracked in adult transgenic and non-transgenic FVB mice, and mammary glands collected at the four different stages of the cycle. Dissected mammary glands were assessed for cyclical morphological changes, proliferation and apoptosis of epithelium, macrophage abundance and collagen deposition, and mRNA encoding matrix remodelling enzymes. Another cohort of control and transgenic mice received carcinogen 7,12-Dimethylbenz(a)anthracene (DMBA) and tumour development was monitored weekly. CCL2 protein was also quantified in paired samples of human breast tissue with high and low mammographic density. Overexpression of CCL2 in the mammary epithelium resulted in an increased number of macrophages, increased density of stroma and collagen and elevated mRNA encoding matrix remodelling enzymes lysyl oxidase (LOX) and tissue inhibitor of matrix metalloproteinases (TIMP)3 compared to non-transgenic controls. Transgenic mice also exhibited increased susceptibility to development of DMBA-induced mammary tumours. In a paired sample cohort of human breast tissue, abundance of epithelial-cell-associated CCL2 was higher in breast tissue of high mammographic density compared to tissue of low mammographic density. Constitutive expression of CCL2 by the mouse mammary epithelium induces a state of low level chronic inflammation that increases stromal density and elevates cancer risk. We propose that CCL2-driven inflammation contributes to the increased risk of breast cancer observed in women with high mammographic density.Keywords
Funding Information
- National Breast Cancer Foundation
- Hospital Research Foundation
- Florey Medical Research Foundation
- Wellcome Trust
- Medical Research Council Centre for Reproductive Health
- National Institutes of Health
- Victorian Breast Cancer Research Consortium
- St. Vincent’s Hospital Research Endowment Fund
- University of Melbourne Research Grant Support Scheme
This publication has 65 references indexed in Scilit:
- CCL2 recruits inflammatory monocytes to facilitate breast-tumour metastasisNature, 2011
- Macrophage Diversity Enhances Tumor Progression and MetastasisCell, 2010
- Immunity, Inflammation, and CancerCell, 2010
- Matrix Crosslinking Forces Tumor Progression by Enhancing Integrin SignalingCell, 2009
- Chemokine (C-C Motif) Ligand 2 Engages CCR2+ Stromal Cells of Monocytic Origin to Promote Breast Cancer Metastasis to Lung and BoneJournal of Biological Chemistry, 2009
- Monocyte Chemoattractant Protein-1 (MCP-1): An OverviewJournal of Interferon & Cytokine Research, 2009
- Important Roles for Macrophage Colony-stimulating Factor, CC Chemokine Ligand 2, and Mononuclear Phagocytes in the Pathogenesis of Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2007
- Macrophages promote collagen fibrillogenesis around terminal end buds of the developing mammary glandDevelopmental Dynamics, 2006
- MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesityJournal of Clinical Investigation, 2006
- Cytokines in cancer pathogenesis and cancer therapyNature Reviews Cancer, 2004